论文部分内容阅读
甲型肝炎(甲肝)灭活疫苗(Hepatitis A Inactivated Vaccine,HepA)于1995年在美国上市,并获准用于≥2岁人群甲肝病毒(Hepatitis A Virus HAV)暴露前免疫,美国食品和药品管理局(FDA)于2005年批准HepA可用于12～23月龄儿童。美国免疫实施咨询委员会(ACIP)分别于1996、1999、2006年
Hepatitis A Inactivated Vaccine (HepA) was marketed in the United States in 1995 and is approved for pre-exposure Hepatitis A Virus HAV exposure in people over 2 years of age. The United States Food and Drug Administration (FDA) approved HepA in 2005 for children 12 to 23 months of age. The Advisory Committee on Immunization Implementation (ACIP) in 1996, 1999, 2006 respectively